Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl-2,2,3,3,5,5,6,6-d8](tetrahydro-2-furanyl)
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Terazosin-d8 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Terazosin-d8 usage and description
Terazosin D8 is a deuterium-labeled version of the selective alpha-1 adrenergic receptor antagonist Terazosin. It is primarily used for the treatment of hypertension and benign prostatic hyperplasia (BPH). Terazosin D8 works by relaxing the smooth muscles in the prostate gland, bladder neck, and urethra, allowing for easier urination and a decrease in blood pressure.
Terazosin D8 is administered orally and is available in tablet form. The recommended dose for hypertension is 1-5 mg once daily, while the recommended dose for BPH is 1-10 mg once daily. It is important to follow the prescribed dosage and not to abruptly stop taking Terazosin D8, as this can cause a sudden increase in blood pressure.
In terms of chemical information, Terazosin D8 has a molecular weight of 468.64 g/mol and a chemical formula of C19H24D8N3O4. It is a white to off-white crystalline powder that is soluble in water. The deuterium labeling in Terazosin D8 is used in pharmacokinetic studies to distinguish it from the non-deuterated version of the drug.
Like any medication, Terazosin D8 does have potential side effects, including dizziness, tiredness, headache, and nasal congestion. It is important to talk to a healthcare provider before starting Terazosin D8 to ensure it is the appropriate medication for the individual's condition.
